BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

791 related articles for article (PubMed ID: 31306767)

  • 1. Role of acyl-CoA synthetase ACSL4 in arachidonic acid metabolism.
    Kuwata H; Hara S
    Prostaglandins Other Lipid Mediat; 2019 Oct; 144():106363. PubMed ID: 31306767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-chain acyl-CoA synthetase 4 participates in the formation of highly unsaturated fatty acid-containing phospholipids in murine macrophages.
    Kuwata H; Nakatani E; Shimbara-Matsubayashi S; Ishikawa F; Shibanuma M; Sasaki Y; Yoda E; Nakatani Y; Hara S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Nov; 1864(11):1606-1618. PubMed ID: 31376475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of long-chain acyl-coenzyme A synthetases in the regulation of arachidonic acid metabolism in interleukin 1β-stimulated rat fibroblasts.
    Kuwata H; Yoshimura M; Sasaki Y; Yoda E; Nakatani Y; Kudo I; Hara S
    Biochim Biophys Acta; 2014 Jan; 1841(1):44-53. PubMed ID: 24095834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of long-chain acyl-CoA synthetase 4 in formation of polyunsaturated lipid species in hepatic stellate cells.
    Tuohetahuntila M; Spee B; Kruitwagen HS; Wubbolts R; Brouwers JF; van de Lest CH; Molenaar MR; Houweling M; Helms JB; Vaandrager AB
    Biochim Biophys Acta; 2015 Feb; 1851(2):220-30. PubMed ID: 25500141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis on the Substrate Specificity of Recombinant Human Acyl-CoA Synthetase ACSL4 Variants.
    Shimbara-Matsubayashi S; Kuwata H; Tanaka N; Kato M; Hara S
    Biol Pharm Bull; 2019; 42(5):850-855. PubMed ID: 31061331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproate uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: relevance to valproate's efficacy against bipolar disorder.
    Shimshoni JA; Basselin M; Li LO; Coleman RA; Rapoport SI; Modi HR
    Biochim Biophys Acta; 2011 Mar; 1811(3):163-9. PubMed ID: 21184843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diminished acyl-CoA synthetase isoform 4 activity in INS 832/13 cells reduces cellular epoxyeicosatrienoic acid levels and results in impaired glucose-stimulated insulin secretion.
    Klett EL; Chen S; Edin ML; Li LO; Ilkayeva O; Zeldin DC; Newgard CB; Coleman RA
    J Biol Chem; 2013 Jul; 288(30):21618-29. PubMed ID: 23766516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for long-chain acyl-CoA synthetase-4 (ACSL4) in diet-induced phospholipid remodeling and obesity-associated adipocyte dysfunction.
    Killion EA; Reeves AR; El Azzouny MA; Yan QW; Surujon D; Griffin JD; Bowman TA; Wang C; Matthan NR; Klett EL; Kong D; Newman JW; Han X; Lee MJ; Coleman RA; Greenberg AS
    Mol Metab; 2018 Mar; 9():43-56. PubMed ID: 29398618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of ACSL4 in the chemical-induced cell death in human proximal tubule epithelial HK-2 cells.
    Kuwata H; Tomitsuka Y; Yoda E; Hara S
    Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35103282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valnoctamide, a non-teratogenic amide derivative of valproic acid, inhibits arachidonic acid activation in vitro by recombinant acyl-CoA synthetase-4.
    Modi HR; Basselin M; Rapoport SI
    Bipolar Disord; 2014 Dec; 16(8):875-80. PubMed ID: 25041123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid-Specific Deficiency of
    Reeves AR; Sansbury BE; Pan M; Han X; Spite M; Greenberg AS
    J Immunol; 2021 Dec; 207(11):2744-2753. PubMed ID: 34725110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of long-chain acyl-CoA synthetase 4 facilitates production of 5, 11-dihydroxyeicosatetraenoic acid via the cyclooxygenase-2 pathway.
    Kuwata H; Hara S
    Biochem Biophys Res Commun; 2015 Sep; 465(3):528-33. PubMed ID: 26282205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional interaction between acyl-CoA synthetase 4, lipooxygenases and cyclooxygenase-2 in the aggressive phenotype of breast cancer cells.
    Maloberti PM; Duarte AB; Orlando UD; Pasqualini ME; Solano AR; López-Otín C; Podestá EJ
    PLoS One; 2010 Nov; 5(11):e15540. PubMed ID: 21085606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Acyl-CoA synthetase isoforms in pancreatic beta cells: Gene silencing shows participation of ACSL3 and ACSL4 in insulin secretion.
    Ansari IH; Longacre MJ; Stoker SW; Kendrick MA; O'Neill LM; Zitur LJ; Fernandez LA; Ntambi JM; MacDonald MJ
    Arch Biochem Biophys; 2017 Mar; 618():32-43. PubMed ID: 28193492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propylisopropylacetic acid (PIA), a constitutional isomer of valproic acid, uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: a potential drug for bipolar disorder.
    Modi HR; Basselin M; Taha AY; Li LO; Coleman RA; Bialer M; Rapoport SI
    Biochim Biophys Acta; 2013 Apr; 1831(4):880-6. PubMed ID: 23354024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine phosphatase SHP2 regulates the expression of acyl-CoA synthetase ACSL4.
    Cooke M; Orlando U; Maloberti P; Podestá EJ; Cornejo Maciel F
    J Lipid Res; 2011 Nov; 52(11):1936-48. PubMed ID: 21903867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The endogenous subcellular localisations of the long chain fatty acid-activating enzymes ACSL3 and ACSL4 in sarcoma and breast cancer cells.
    Radif Y; Ndiaye H; Kalantzi V; Jacobs R; Hall A; Minogue S; Waugh MG
    Mol Cell Biochem; 2018 Nov; 448(1-2):275-286. PubMed ID: 29450800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arachidonic acid downregulates acyl-CoA synthetase 4 expression by promoting its ubiquitination and proteasomal degradation.
    Kan CF; Singh AB; Stafforini DM; Azhar S; Liu J
    J Lipid Res; 2014 Aug; 55(8):1657-67. PubMed ID: 24879802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Chain Acyl-CoA Synthetase 4-Mediated Fatty Acid Metabolism Sustains Androgen Receptor Pathway-Independent Prostate Cancer.
    Ma Y; Zhang X; Alsaidan OA; Yang X; Sulejmani E; Zha J; Beharry Z; Huang H; Bartlett M; Lewis Z; Cai H
    Mol Cancer Res; 2021 Jan; 19(1):124-135. PubMed ID: 33077484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of p115 as a novel ACSL4 interacting protein and its role in regulating ACSL4 degradation.
    Sen P; Kan CFK; Singh AB; Rius M; Kraemer FB; Sztul E; Liu J
    J Proteomics; 2020 Oct; 229():103926. PubMed ID: 32736139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.